​

Nuvation Bio (NUVB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Nuvation Bio Revenue Highlights

Latest Revenue (Y)

$7.87M

Latest Revenue (Q)

$727.00K

Main Segment (Y)

License Revenue

Main Geography (Y)

CHINA

Nuvation Bio Revenue by Period

Nuvation Bio Revenue by Year

DateRevenueChange
2024-12-31$7.87M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Nuvation Bio generated $7.87M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Nuvation Bio Revenue by Quarter

DateRevenueChange
2024-09-30$727.00K-49.34%
2024-06-30$1.44M100.00%
2024-03-31--100.00%
2023-12-31$264.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Nuvation Bio generated $727.00K in revenue during Q3 2024, up -49.34% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Nuvation Bio Revenue Breakdown

Nuvation Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
License Revenue$2.09M

Nuvation Bio's latest annual revenue breakdown by segment (product or service), as of Dec 24: License Revenue (100.00%).

Nuvation Bio Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
JAPAN$2.70M
CHINA$5.20M

Nuvation Bio's latest annual revenue breakdown by geography, as of Dec 24: CHINA (65.82%), and JAPAN (34.18%).

Quarterly Revenue by Country

CountryDec 24Sep 24
CHINA$5.10M$100.00K
JAPAN$2.10M$600.00K

Nuvation Bio's latest quarterly revenue breakdown by geography, as of Dec 24: CHINA (70.83%), and JAPAN (29.17%).

Nuvation Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$138.10M$33.43M
SPROSpero Therapeutics$47.98M$13.47M
NUVBNuvation Bio$7.87M$727.00K
ACHLAchilles Therapeutics--
NXTCNextCure--
TILInstil Bio--
ASMBAssembly Biosciences-$6.84M

NUVB Revenue FAQ

What is Nuvation Bio’s yearly revenue?

Nuvation Bio's yearly revenue for 2024 was $7.87M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. NUVB's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Nuvation Bio’s quarterly revenue?

Nuvation Bio's quarterly revenue for Q3 2024 was $727K, a -49.34% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.44M, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). NUVB's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Nuvation Bio’s revenue growth rate?

Nuvation Bio's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Nuvation Bio’s revenue streams?

Nuvation Bio's revenue streams in c 24 are License Revenue

What is Nuvation Bio’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Nuvation Bio was License Revenue. This segment made a revenue of $2.09M, representing 100.00% of the company's total revenue.